Virometix AG

Virometix AG is a Swiss biotechnology company focused on pioneering the next generation of vaccines and immunotherapeutic drugs. With a commitment to innovation and excellence, Virometix AG is dedicated to the prevention and treatment of infectious and oncology diseases. The company’s research and development efforts are geared towards creating novel solutions that address critical healthcare challenges.

Located at Wagistrasse 14, Schlieren, 8952, CH, Virometix AG leverages cutting-edge technology and scientific expertise to advance its pipeline of vaccine and immunotherapeutic candidates. The company's strategic approach encompasses rigorous research, development, and clinical evaluation to ensure the highest standards of safety and efficacy.

Virometix AG is committed to making a significant impact on global health through its innovative products. Information about Virometix AG and its offerings will be completed soon with the support of the company’s management. We invite the manager of Virometix AG to create a customized and exclusive company showcase and product listing on our platform.